Gå offline med appen Player FM !
Podcaster värda att lyssna på
SPONSRAD
![We Have The Receipts podcast artwork](https://cdn.player.fm/images/37350108/series/3hptiqPGSZRELxyS/32.jpg 32w, https://cdn.player.fm/images/37350108/series/3hptiqPGSZRELxyS/64.jpg 64w, https://cdn.player.fm/images/37350108/series/3hptiqPGSZRELxyS/128.jpg 128w, https://cdn.player.fm/images/37350108/series/3hptiqPGSZRELxyS/256.jpg 256w, https://cdn.player.fm/images/37350108/series/3hptiqPGSZRELxyS/512.jpg 512w)
![We Have The Receipts podcast artwork](/static/images/64pixel.png)
1 Love Is Blind S8: Pods & Sober High Thoughts with Courtney Revolution & Meg 1:06:00
#13 How to talk about risks – Alexandra Freeman
Manage episode 424661255 series 2749727
People’s perception of risk can vary greatly from person to person, making it challenging for healthcare professionals to communicate benefits and harms of medicines in a balanced fashion. Alexandra Freeman from the Winton Centre for Risk and Evidence Communication discusses how to give patients the information they need to decide what's best for them.
Tune in to find out:
- Why people perceive risks so differently
- Why medical communicators should strive to inform rather than persuade
- How to communicate in a trustworthy fashion
Want to know more?
- There is no right way to communicate evidence to patients, but there are a few things you can do to avoid getting it wrong.
- Conventional communication techniques are good for persuading people – but when the aim is to inform, the principles of evidence communication should be applied instead.
- Graphics can help people translate abstract numbers into contextualised risks they can relate to, like these visuals that illustrate the risk of blood clots with the AstraZeneca COVID-19 vaccine.
- These evidence-based guidelines can help professional communicators illustrate the personalised risk of dying from COVID-19.
- The Winton Centre offers plenty of resources on risk and evidence communication, including free e-learning courses for healthcare professionals, the Risky Talk podcast with statistician David Spiegelhalter, and the RealRisk tool to help healthcare professionals and communicators extract the right statistics from academic papers.
For more on communicating benefits and harms in pharmacovigilance, revisit this Drug Safety Matters episode on vaccine safety communication.
Join the conversation on social media
Follow us on X, LinkedIn, or Facebook and share your thoughts about the show with the hashtag #DrugSafetyMatters.
Got a story to share?
We’re always looking for new content and interesting people to interview. If you have a great idea for a show, get in touch!
About UMC
Read more about Uppsala Monitoring Centre and how we work to advance medicines safety.
52 episoder
Manage episode 424661255 series 2749727
People’s perception of risk can vary greatly from person to person, making it challenging for healthcare professionals to communicate benefits and harms of medicines in a balanced fashion. Alexandra Freeman from the Winton Centre for Risk and Evidence Communication discusses how to give patients the information they need to decide what's best for them.
Tune in to find out:
- Why people perceive risks so differently
- Why medical communicators should strive to inform rather than persuade
- How to communicate in a trustworthy fashion
Want to know more?
- There is no right way to communicate evidence to patients, but there are a few things you can do to avoid getting it wrong.
- Conventional communication techniques are good for persuading people – but when the aim is to inform, the principles of evidence communication should be applied instead.
- Graphics can help people translate abstract numbers into contextualised risks they can relate to, like these visuals that illustrate the risk of blood clots with the AstraZeneca COVID-19 vaccine.
- These evidence-based guidelines can help professional communicators illustrate the personalised risk of dying from COVID-19.
- The Winton Centre offers plenty of resources on risk and evidence communication, including free e-learning courses for healthcare professionals, the Risky Talk podcast with statistician David Spiegelhalter, and the RealRisk tool to help healthcare professionals and communicators extract the right statistics from academic papers.
For more on communicating benefits and harms in pharmacovigilance, revisit this Drug Safety Matters episode on vaccine safety communication.
Join the conversation on social media
Follow us on X, LinkedIn, or Facebook and share your thoughts about the show with the hashtag #DrugSafetyMatters.
Got a story to share?
We’re always looking for new content and interesting people to interview. If you have a great idea for a show, get in touch!
About UMC
Read more about Uppsala Monitoring Centre and how we work to advance medicines safety.
52 episoder
Alla avsnitt
×![Drug Safety Matters podcast artwork](/static/images/64pixel.png)
1 #35 Veterinary pharmacovigilance part 2 – James Mount 41:42
![Drug Safety Matters podcast artwork](/static/images/64pixel.png)
1 #34 Veterinary pharmacovigilance, Part I – James Mount 47:21
![Drug Safety Matters podcast artwork](/static/images/64pixel.png)
1 #33 Narrative fields and signal assessors, an exploratory study – Joana Félix and Alem Zekarias 38:43
![Drug Safety Matters podcast artwork](/static/images/64pixel.png)
1 #32 Pharmacovigilance in older adults – Giovanni Furlan 47:51
![Drug Safety Matters podcast artwork](/static/images/64pixel.png)
1 #31 A guide to reporting disproportionality analyses – Michele Fusaroli and Daniele Sartori 42:45
![Drug Safety Matters podcast artwork](/static/images/64pixel.png)
1 Uppsala Reports Long Reads – Weeding out duplicates to better detect side effects 25:02
![Drug Safety Matters podcast artwork](/static/images/64pixel.png)
1 Uppsala Reports Long Reads – Ensuring trust in AI/ML when used in pharmacovigilance 30:18
![Drug Safety Matters podcast artwork](/static/images/64pixel.png)
1 #30 Preventing and reporting medication errors – Rabat CC & UMC 33:58
![Drug Safety Matters podcast artwork](/static/images/64pixel.png)
1 #29 When medicines change our behaviour – Michele Fusaroli 30:30
![Drug Safety Matters podcast artwork](/static/images/64pixel.png)
1 #28 Catching black swans – François Montastruc 27:21
![Drug Safety Matters podcast artwork](/static/images/64pixel.png)
1 #27 When drugs damage the liver – Rita Baião 28:30
![Drug Safety Matters podcast artwork](/static/images/64pixel.png)
1 #26 What's trending in pharmacovigilance? – Angela Caro 28:06
![Drug Safety Matters podcast artwork](/static/images/64pixel.png)
1 #25 A week in the name of medicines safety – part 2 33:13
![Drug Safety Matters podcast artwork](/static/images/64pixel.png)
1 #24 A week in the name of medicines safety – part 1 27:09
![Drug Safety Matters podcast artwork](/static/images/64pixel.png)
1 Uppsala Reports Long Reads – The colour of signals 33:59
Välkommen till Player FM
Player FM scannar webben för högkvalitativa podcasts för dig att njuta av nu direkt. Den är den bästa podcast-appen och den fungerar med Android, Iphone och webben. Bli medlem för att synka prenumerationer mellan enheter.